BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

HemoShear, LLC Adds Industry Veterans Mehmood Khan and Fred Brown to Board of Managers


11/13/2012 11:12:56 AM

CHARLOTTESVILLE, Va., Nov. 13, 2012 /PRNewswire/ -- HemoShear LLC, a biotechnology research company and leading developer of human-relevant systems for discovery and assessment of new drug compounds, today announced that two successful pharmaceutical industry veterans have joined its Board of Managers.  Mehmood Khan, M.D., Executive Vice President and Chief Scientific Officer, Global Research and Development for PepsiCo, Inc., and Frederick W. K. Brown, M.B.A., Chief Innovation and New Venture Officer at Ascension Health in Michigan, have agreed to serve on HemoShear's Board.

(Logo: http://photos.prnewswire.com/prnh/20120416/PH86899LOGO)

"We are thrilled to have Mehmood and Fred join our board," said Jim Powers, HemoShear's CEO. "The building of a great company requires the leadership of a distinguished Board of Managers with records of success in building and leading commercial enterprises within the pharmaceutical industry. I am proud that HemoShear was able to gain the support of such prominent individuals. As we move forward with our plans to transform the productivity of pharmaceutical R&D, the experience and perspectives of Dr. Khan and Mr. Brown will be extremely valuable."

As PepsiCo's EVP and Chief Scientific Officer, Dr. Khan leads PepsiCo's research and development efforts, including nutrition, medicine, research, science, marketing/branding, and product innovation. He also directs PepsiCo's enterprise planning, portfolio development, and implementation of new technologies to grow PepsiCo's nutrition-focused brands. Prior to joining PepsiCo, Dr. Khan was President, Takeda Global Research & Development Center, overseeing Takeda's worldwide R&D efforts. He joined Takeda after serving as Director of the Diabetes, Endocrine and Nutrition Clinical Trials Unit and as Senior Associate Consultant in the Division of Endocrinology at the Mayo Clinic.

Prior to joining Ascension Health, Mr. Brown was President of the Navigator Health Services division of Diplomat Specialty Pharmacy, the largest independent specialty pharmacy in the world, which was awarded the INC 500 prize as the fastest growing healthcare company in the U.S. in 2009 and 2010.  Before that he served as Global Head of Partnering and Product Lifecycle Management at Hoffmann-La Roche.  As a top healthcare consultant, Mr. Brown served as Executive Vice President, Global Services EMEA, of the Life Sciences/Healthcare Division of IBM, and he co-founded Anderson Consulting's (now Accenture's) Pharmaceutical and Medicinal Products Practice in the US and Europe. 

About HemoShear LLC
By applying physiologically accurate hemodynamics and biological transport to primary cell cultures, HemoShear creates human-relevant systems that accurately replicate the biology of organ systems and diseases throughout drug discovery and development. Working in strategic partnerships with pharmaceutical, biotechnology and medical device companies, HemoShear generates meaningful data to increase confidence in decision-making, reduce risk of costly failures and identify efficacious therapies. HemoShear's science leads to new medicines and improves human health.  

SOURCE HemoShear LLC



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES